SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008392
Filing Date
2023-05-08
Accepted
2023-05-08 08:56:47
Documents
80
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20230331x10q.htm   iXBRL 10-Q 1537248
2 EX-10.1 lqda-20230331xex10d1.htm EX-10.1 27991
3 EX-10.2 lqda-20230331xex10d2.htm EX-10.2 386048
4 EX-10.3 lqda-20230331xex10d3.htm EX-10.3 44297
5 EX-31.1 lqda-20230331xex31d1.htm EX-31.1 15295
6 EX-31.2 lqda-20230331xex31d2.htm EX-31.2 15296
7 EX-32.1 lqda-20230331xex32d1.htm EX-32.1 7557
8 EX-32.2 lqda-20230331xex32d2.htm EX-32.2 7536
9 GRAPHIC lqda-20230331x10q001.jpg GRAPHIC 631
  Complete submission text file 0001558370-23-008392.txt   7422958

Data Files

Seq Description Document Type Size
10 EX-101.SCH lqda-20230331.xsd EX-101.SCH 62959
11 EX-101.CAL lqda-20230331_cal.xml EX-101.CAL 42182
12 EX-101.DEF lqda-20230331_def.xml EX-101.DEF 208431
13 EX-101.LAB lqda-20230331_lab.xml EX-101.LAB 498913
14 EX-101.PRE lqda-20230331_pre.xml EX-101.PRE 372979
74 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20230331x10q_htm.xml XML 1058686
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 23896073
SIC: 2834 Pharmaceutical Preparations